240 related articles for article (PubMed ID: 20346232)
1. Development of new osteonecrosis in systemic lupus erythematosus patients in association with long-term corticosteroid therapy after disease recurrence.
Nakamura J; Ohtori S; Sakamoto M; Chuma A; Abe I; Shimizu K
Clin Exp Rheumatol; 2010; 28(1):13-8. PubMed ID: 20346232
[TBL] [Abstract][Full Text] [Related]
2. Age at time of corticosteroid administration is a risk factor for osteonecrosis in pediatric patients with systemic lupus erythematosus: a prospective magnetic resonance imaging study.
Nakamura J; Saisu T; Yamashita K; Suzuki C; Kamegaya M; Takahashi K
Arthritis Rheum; 2010 Feb; 62(2):609-15. PubMed ID: 20112393
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous repair of asymptomatic osteonecrosis associated with corticosteroid therapy in systemic lupus erythematosus: 10-year minimum follow-up with MRI.
Nakamura J; Harada Y; Oinuma K; Iida S; Kishida S; Takahashi K
Lupus; 2010 Oct; 19(11):1307-14. PubMed ID: 20605878
[TBL] [Abstract][Full Text] [Related]
4. Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study.
Shigemura T; Nakamura J; Kishida S; Harada Y; Ohtori S; Kamikawa K; Ochiai N; Takahashi K
Rheumatology (Oxford); 2011 Nov; 50(11):2023-8. PubMed ID: 21865285
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroids and low bone mineral density affect hip cartilage in systemic lupus erythematosus patients: Quantitative T2 mapping.
Hagiwara S; Nakamura J; Watanabe A; Kishida S; Ohtori S; Omae T; Miyamoto S; Orita S; Takahashi K
J Magn Reson Imaging; 2015 Dec; 42(6):1524-31. PubMed ID: 26019059
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus.
Kwon HH; Bang SY; Won S; Park Y; Yi JH; Joo YB; Lee HS; Bae SC
Lupus; 2018 Sep; 27(10):1644-1651. PubMed ID: 29950160
[TBL] [Abstract][Full Text] [Related]
7. Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment.
Oinuma K; Harada Y; Nawata Y; Takabayashi K; Abe I; Kamikawa K; Moriya H
Ann Rheum Dis; 2001 Dec; 60(12):1145-8. PubMed ID: 11709458
[TBL] [Abstract][Full Text] [Related]
8. [Clinical research of correlation between osteonecrosis and steroid].
Li ZR; Sun W; Qu H; Zhou YX; Dou BX; Shi ZC; Zhang NF; Cheng XG; Wang DL; Guo WS
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(16):1048-53. PubMed ID: 16194330
[TBL] [Abstract][Full Text] [Related]
9. The role of non-corticosteroid related factors in osteonecrosis (ON) in systemic lupus erythematosus: a nested case-control study of inception patients.
Prasad R; Ibanez D; Gladman D; Urowitz M
Lupus; 2007; 16(3):157-62. PubMed ID: 17432099
[TBL] [Abstract][Full Text] [Related]
10. [Recurrent avascular bone necrosis in systemic lupus].
Abu-Shakra M; Sukenik S; Shoenfeld Y
Harefuah; 1989 Feb; 116(4):197-9. PubMed ID: 2731786
[TBL] [Abstract][Full Text] [Related]
11. Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies.
Migliaresi S; Picillo U; Ambrosone L; Di Palma G; Mallozzi M; Tesone ER; Tirri G
Lupus; 1994 Feb; 3(1):37-41. PubMed ID: 8025584
[TBL] [Abstract][Full Text] [Related]
12. Transitional changes in the incidence of osteonecrosis in systemic lupus erythematosus patients: focus on immunosuppressant agents and glucocorticoids.
Nawata K; Nakamura J; Ikeda K; Furuta S; Nakajima H; Ohtori S; Hagiwara S; Wako Y; Miura M; Kawarai Y; Sugano M; Yoshino K; Orita S; Inage K; Akazawa T
Rheumatology (Oxford); 2018 May; 57(5):844-849. PubMed ID: 29462407
[TBL] [Abstract][Full Text] [Related]
13. Recovery of the blood flow around the femoral head during early corticosteroid therapy: dynamic magnetic resonance imaging in systemic lupus erythematosus patients.
Nakamura J; Ohtori S; Watanabe A; Nakagawa K; Inoue G; Kishida S; Harada Y; Suzuki M; Takahashi K
Lupus; 2012 Mar; 21(3):264-70. PubMed ID: 22020268
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for Symptomatic Avascular Necrosis in Childhood-onset Systemic Lupus Erythematosus.
Yang Y; Kumar S; Lim LS; Silverman ED; Levy DM
J Rheumatol; 2015 Dec; 42(12):2304-9. PubMed ID: 26568601
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of multifocal osteonecrosis in Korean patients with rheumatic disease.
Jeong HJ; Kim D; Cho SK; Kim Y; Bae SC; Sung YK
Int J Rheum Dis; 2018 Jun; 21(6):1301-1308. PubMed ID: 28328178
[TBL] [Abstract][Full Text] [Related]
16. High-Dose Corticosteroid Use and Risk of Hip Osteonecrosis: Meta-Analysis and Systematic Literature Review.
Mont MA; Pivec R; Banerjee S; Issa K; Elmallah RK; Jones LC
J Arthroplasty; 2015 Sep; 30(9):1506-1512.e5. PubMed ID: 25900167
[TBL] [Abstract][Full Text] [Related]
17. Symptomatic osteonecrosis of the hip and knee in patients with systemic lupus erythematosus: Prevalence, pattern, and comparison of natural course.
Ersin M; Demirel M; Ekinci M; Mert L; Çetin Ç; Artım Esen B; İnanç M; Kılıçoğlu ÖI
Lupus; 2021 Sep; 30(10):1603-1608. PubMed ID: 34259056
[TBL] [Abstract][Full Text] [Related]
18. Osteonecrosis in systemic lupus erythematosus.
Gontero RP; Bedoya ME; Benavente E; Roverano SG; Paira SO
Reumatol Clin; 2015; 11(3):151-5. PubMed ID: 25441491
[TBL] [Abstract][Full Text] [Related]
19. Damage in systemic lupus erythematosus and its association with corticosteroids.
Zonana-Nacach A; Barr SG; Magder LS; Petri M
Arthritis Rheum; 2000 Aug; 43(8):1801-8. PubMed ID: 10943870
[TBL] [Abstract][Full Text] [Related]
20. Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?
Karp I; Abrahamowicz M; Fortin PR; Pilote L; Neville C; Pineau CA; Esdaile JM
Arthritis Rheum; 2008 Feb; 59(2):169-75. PubMed ID: 18240259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
